BIOCHEMICAL AND MS CHARACTERIZATION OF WERNER PROTEIN INTERACTION NETWORK
Werner 蛋白质相互作用网络的生化和 MS 表征
基本信息
- 批准号:8171366
- 负责人:
- 金额:$ 0.67万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-09-01 至 2011-08-31
- 项目状态:已结题
- 来源:
- 关键词:AgingAging-Related ProcessBiochemicalBiologicalCellsComplexComputational ScienceComputer Retrieval of Information on Scientific Projects DatabaseDNA DamageDevelopmentDiabetes MellitusDiseaseElderlyEventFundingGenesGenomeGenomicsGrantHumanInstitutionKnowledgeLeadLongevityMalignant NeoplasmsMutationOrganismOsteoporosisPathogenesisPathologyPersonsPopulationPost-Translational Protein ProcessingPredispositionProteinsProteomicsResearchResearch PersonnelResourcesSamplingSeriesSourceUnited States National Institutes of HealthWRN geneWerner SyndromeWorkage relateddemographicsenvironmental agenthelicaseimprovedinsightinstrumentationinterestnovel strategiespreventprotein functionsenescence
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Our focus of research, the Werner protein, is one of disease-associated RecQ helicases. Its deficiency results in the Werner syndrome (WS), characterized by accelerated rate of mutation and the organism's inability to resolve a variety of genome-damaging events. Mutations in the WRN gene (also referred to as RECQ3 or RECQL2) don't appear to increase a person's susceptibility to DNA damage, and they alone do not cause the development of the disease. Instead they accelerate and exacerbate the disease that could develop even without this sensitizing mutation due to the damaging environmental agents.
An important consequence of understanding the mechanism of a pathology is the ability to treat it more effectively, and even to prevent it in some cases. Aging research is extremely important considering the changing demographics worldwide, increased overall longevity and rise in elderly population. Understanding of the mechanisms that underlie aging and development of age-related disease due to genomic aberration can lead us to improved treatment and alleviated burden of age-related disease. Activity of proteins such as WRN suggests that the complex process of ageing is controlled by a conserved number of genes. However, mutations in a series of proteins do not suggest that their normal function is involved in promoting longevity. We are interested in understanding how normal function of this protein stalls senescence.
In order to determine these mechanisms we study protein function in normal and diseased states with the use of proteomics. Resources that are currently available to us include modern analytical instrumentation, support from computational sciences, and access to rare biological samples. Our work is aimed at defining consistently associated proteins and post-translational modifications of WRN that are required or are causal for its function in human cells. This knowledge will increase our understanding of WS pathogenesis and provide insight into novel strategies to alter the progression of WS or associated diseases such as ASCVD, cancer, diabetes, and osteoporosis.
该副本是利用众多研究子项目之一
由NIH/NCRR资助的中心赠款提供的资源。子弹和
调查员(PI)可能已经从其他NIH来源获得了主要资金,
因此可以在其他清晰的条目中代表。列出的机构是
对于中心,这不一定是调查员的机构。
我们的研究重点是Werner蛋白,是与疾病相关的RECQ解旋酶之一。它的缺乏导致Werner综合征(WS),其特征在于突变速率加速和生物体无法解决各种基因组损害事件的特征。 WRN基因中的突变(也称为RECQ3或RECQL2)似乎不会增加一个人对DNA损伤的敏感性,并且仅它们并不会引起疾病的发展。取而代之的是,它们加速并加剧了该疾病,即使没有破坏性的环境药物,这种疾病也可以发展出来。
理解病理机制的重要结果是能够更有效地治疗它,甚至在某些情况下可以防止它。考虑到全球人口统计学变化,总体寿命和老年人口的增长,衰老研究非常重要。了解由于基因组像差引起的与年龄相关疾病的衰老和发展的机制可能导致我们改善治疗并减轻与年龄相关疾病的负担。蛋白质(例如WRN)的活性表明,复杂的衰老过程由保守数量的基因控制。但是,一系列蛋白质中的突变并不表明它们的正常功能涉及促进寿命。我们有兴趣了解该蛋白质衰老的正常功能。
为了确定这些机制,我们通过使用蛋白质组学研究正常和患病状态的蛋白质功能。当前可供我们使用的资源包括现代分析仪器,计算科学的支持以及获得稀有生物样品的访问。我们的工作旨在定义始终相关的蛋白质和对WRN的翻译后修饰,或者是其在人类细胞中功能的因果关系。这些知识将增加我们对WS发病机理的理解,并提供对改变WS或相关疾病(例如ASCVD,癌症,糖尿病和骨质疏松症)的新型策略的见解。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael MacCoss其他文献
Michael MacCoss的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Michael MacCoss', 18)}}的其他基金
Seattle Quant: A Resource for the Skyline Software Ecosystem
Seattle Quant:Skyline 软件生态系统的资源
- 批准号:
10609502 - 财政年份:2021
- 资助金额:
$ 0.67万 - 项目类别:
Seattle Quant: A Resource for the Skyline Software Ecosystem
Seattle Quant:Skyline 软件生态系统的资源
- 批准号:
10400105 - 财政年份:2021
- 资助金额:
$ 0.67万 - 项目类别:
Seattle Quant: A Resource for the Skyline Software Ecosystem
Seattle Quant:Skyline 软件生态系统的资源
- 批准号:
10189938 - 财政年份:2021
- 资助金额:
$ 0.67万 - 项目类别:
Project 1: Discovery of proteins with altered abundance and stability
项目 1:发现丰度和稳定性发生改变的蛋白质
- 批准号:
10359192 - 财政年份:2020
- 资助金额:
$ 0.67万 - 项目类别:
Project 1: Discovery of proteins with altered abundance and stability
项目 1:发现丰度和稳定性发生改变的蛋白质
- 批准号:
10573256 - 财政年份:2020
- 资助金额:
$ 0.67万 - 项目类别:
Next Generation Translational Proteomics for Alzheimer's and Related Dementias
阿尔茨海默氏症和相关痴呆症的下一代转化蛋白质组学
- 批准号:
10573244 - 财政年份:2020
- 资助金额:
$ 0.67万 - 项目类别:
Next Generation Translational Proteomics for Alzheimer's and Related Dementias
阿尔茨海默氏症和相关痴呆症的下一代转化蛋白质组学
- 批准号:
10359187 - 财政年份:2020
- 资助金额:
$ 0.67万 - 项目类别:
相似海外基金
Elucidating the Role of YAP and TAZ in the Aging Human Ovary
阐明 YAP 和 TAZ 在人类卵巢衰老中的作用
- 批准号:
10722368 - 财政年份:2023
- 资助金额:
$ 0.67万 - 项目类别:
Identifying epigenetic factors in control of epidermal stem cell longevity in the adult skin
识别控制成人皮肤表皮干细胞寿命的表观遗传因素
- 批准号:
10723212 - 财政年份:2023
- 资助金额:
$ 0.67万 - 项目类别:
Programming of Epigenetic Clocks and Biomarkers from Early-life Arsenic Exposure
生命早期砷暴露的表观遗传时钟和生物标志物的编程
- 批准号:
10726009 - 财政年份:2023
- 资助金额:
$ 0.67万 - 项目类别:
Function of SMYD lysine methyltransferases in stress responses and proteostasis
SMYD 赖氨酸甲基转移酶在应激反应和蛋白质稳态中的功能
- 批准号:
10745041 - 财政年份:2023
- 资助金额:
$ 0.67万 - 项目类别: